Detalhe da pesquisa
1.
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
Lancet
; 397(10287): 1809-1818, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33964223
2.
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
NPJ Vaccines
; 9(1): 10, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184681
3.
A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults.
J Clin Invest
; 134(7)2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290009
4.
Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans.
Sci Rep
; 13(1): 13904, 2023 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37626150
5.
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Sci Transl Med
; 15(704): eadf1782, 2023 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437014
6.
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial.
Lancet Infect Dis
; 22(12): 1728-1736, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36087586
7.
Impact of a blood-stage vaccine on Plasmodium vivax malaria.
medRxiv
; 2022 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664997
8.
Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccine.
NPJ Vaccines
; 6(1): 120, 2021 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34642303
9.
High degree of conservation of the multigene tryptase locus over the past 150-200 million years of mammalian evolution.
Immunogenetics
; 62(6): 369-82, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20383634
10.
A Reproducible and Scalable Process for Manufacturing a Pfs48/45 Based Plasmodium falciparum Transmission-Blocking Vaccine.
Front Immunol
; 11: 606266, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33505395
11.
Extended substrate specificity of opossum chymase--implications for the origin of mast cell chymases.
Mol Immunol
; 45(7): 2116-25, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18022236
12.
Granzyme-like sequences in bony fish shed light on the emergence of hematopoietic serine proteases during vertebrate evolution.
Dev Comp Immunol
; 30(10): 901-18, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16413608
13.
Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.
Vaccine
; 32(7): 800-8, 2014 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-24380682
14.
Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice.
Vaccine
; 31(13): 1725-33, 2013 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23384754
15.
Human cord blood derived immature basophils show dual characteristics, expressing both basophil and eosinophil associated proteins.
PLoS One
; 7(10): e48308, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23118978
16.
Matrix-M™ adjuvant induces local recruitment, activation and maturation of central immune cells in absence of antigen.
PLoS One
; 7(7): e41451, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22844480
17.
Matrix-M adjuvant: enhancing immune responses by 'setting the stage' for the antigen.
Expert Rev Vaccines
; 12(8): 821-3, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23984954
18.
Expansion of the mast cell chymase locus over the past 200 million years of mammalian evolution.
Immunogenetics
; 58(8): 655-69, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16807745